NCT03034486View on ClinicalTrials.gov

The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 17, 2017

Primary Completion Date

March 17, 2017

Study Completion Date

March 20, 2017

Conditions

Healthy

Interventions

DRUG

D930, D565

Period 1: D565 administered 1 time for one day/ Period 2: D930 administered 3 time per day for 9 days/ Period 3: D565(1 time per day) with D930(3 time per day) administered for 9days

Trial Locations (1)

602-715

Dong-A University Hospital, Seo-gu